Smit E F - AI Profile | 人才画像

基本信息

浏览量：2

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 499 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With BRAF V600 -Mutant Metastatic Non-Small-Cell Lung Cancer

Gregory J Riely,Egbert F Smit,Myung-Ju Ahn,Enriqueta Felip,Suresh S Ramalingam,Anne Tsao,Melissa Johnson,Francesco Gelsomino, Raymond Esper,Ernest Nadal,Michael Offin,Mariano Provencio,

Journal of clinical oncology : official journal of the American Society of Clinical Oncologyno. 21 (2023): 3700-+

引用0浏览0WOS引用

Tobacco Smoking-Related Mutational Signatures in Classifying Smoking-Associated and Nonsmoking-Associated NSCLC

Sophie M Ernst,Joanne M Mankor,Job van Riet,Jan H von der Thüsen, Hendrikus J Dubbink,Joachim G J V Aerts,Adrianus J de Langen,Egbert F Smit,Anne-Marie C Dingemans,Kim Monkhorst

J Thorac Oncol（2023）

引用2浏览0WOS引用

Safety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertions

Zofia Piotrowska,Daniel Shao-Weng Tan,Egbert F Smit,Alexander I Spira,Ross A Soo,Danny Nguyen,Victor Ho-Fun Lee,James Chih-Hsin Yang,Vamsidhar Velcheti,John M Wrangle,Mark A Socinski,Marianna Koczywas,

Journal of clinical oncology : official journal of the American Society of Clinical Oncologyno. 26 (2023): 4218-+

引用0浏览0WOS引用

Analysis of significant weight gain in patients using alectinib for ALK-positive lung cancer

Barend Joel Sikkema, Simon de Leeuw, Melinda Pruis, Mostafa Mohseni, Geerten Dieuwert Marijn Veerman,Marthe Paats,Daphne W. Dumoulin,Egbert F. Smit,Annemie M. W. J. Schols,Ron H. J. Mathijssen,Elisabeth Van Rossum,Anne-Marie C. Dingemans

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

Efficacy and safety of encorafenib (enco) plus binimetinib (bini) in patients with BRAF V600E-mutant (BRAF(V600E)) metastatic non-small cell lung cancer (NSCLC) from the phase 2 PHAROS study

Gregory J. Riely,Egbert F. Smit,Myung-Ju Ahn,Enriqueta Felip,Suresh S. Ramalingam,Anne S. Tsao, Melissa Lynne Johnson,Francesco Gelsomino, Raymond M. Esper,Ernest Nadal,Michael Offin, Mariano Provencio-Pulla,

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

Poziotinib for HER2 Exon 20-Mutated NSCLC: Addition or Burden to the Therapeutic Arsenal

Frank J Borm,Egbert F Smit

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancerno. 8 (2023): 964-966

引用0浏览0WOS引用

Supplementary Tables S1 and S2 from Reduced <i>NF1</i> Expression Confers Resistance to EGFR Inhibition in Lung Cancer

Elza C. de Bruin, Catherine Cowell, Patricia H. Warne, Ming Jiang, Rebecca E. Saunders, Mary Ann Melnick,Scott Gettinger,Zenta Walther, Anna Wurtz, Guus J. Heynen,Daniëlle A.M. Heideman,Javier Gómez-Román,

crossref（2023）

引用0浏览0引用

Computed tomography-based radiomics for the differential diagnosis of pneumonitis in stage IV non-small cell lung cancer patients treated with immune checkpoint inhibitors

Fariba Tohidinezhad,Dennis Bontempi,Zhen Zhang,Anne-Marie Dingemans,Joachim Aerts,Gerben Bootsma,Johan Vansteenkiste,Sayed Hashemi,Egbert Smit, Hester Gietema,Hugo Jwl Aerts,Andre Dekker,

Eur J Cancer（2023）

引用0浏览0WOS引用

Trastuzumab Deruxtecan in Patients With HER2 -Mutant Metastatic Non-Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial

Koichi Goto,Yasushi Goto,Toshio Kubo, Kiichiro Ninomiya,Sang-We Kim, David Planchard,Myung-Ju Ahn,Egbert F Smit,Adrianus Johannes de Langen,Maurice Pérol,Elvire Pons-Tostivint,Silvia Novello,

Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)

引用0浏览0WOS引用

Clinical Relevance of High Plasma Trough Levels of the Kinase Inhibitors Crizotinib, Alectinib, Osimertinib, Dabrafenib, and Trametinib in NSCLC Patients

Lishi Lin,Hannerieke J Barkman,Egbert F Smit, Adrianus J de Langen,Neeltje Steeghs,Jos H Beijnen,Alwin D R Huitema

Therapeutic drug monitoring (2023)

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn